Downregulated Mucosal Autophagy, Alpha Kinase-1 and IL-17 Signaling Pathways in Active and Quiescent Ulcerative Colitis (original) (raw)

News from the “5th international meeting on inflammatory bowel diseases” CAPRI 2010

Journal of Crohn's and Colitis, 2010

Molecular Signature of Persistent Histological Inflammation in Ulcerative Colitis with Mucosal Healing

Journal of Gastrointestinal and Liver Diseases

Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations

Miriam Esteller

Gut, 2013

View PDFchevron_right

Signaling for inflammation and repair in inflammatory bowel disease

Manuela Neuman

Romanian journal of gastroenterology, 2004

View PDFchevron_right

Maximizing the diagnostic information from biopsies in chronic inflammatory bowel diseases: recommendations from the Erlangen International Consensus Conference on Inflammatory Bowel Diseases and presentation of the IBD-DCA score as a proposal for a new index for histologic activity assessment in...

Kateřina Kamarádová

Virchows Archiv

View PDFchevron_right

Mucosal gene transcription of ulcerative colitis in endoscopic remission

Rasmus Goll

Scandinavian Journal of Gastroenterology, 2020

View PDFchevron_right

Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation

Bas Oldenburg

Inflammatory Bowel Diseases, 2012

View PDFchevron_right

Pathogenesis of Ulcerative Colitis and Crohn’s Disease: Similarities, Differences and a Lot of Things We Do Not Know Yet

Anita Annaházi

Journal of Clinical & Cellular Immunology, 2014

View PDFchevron_right

New insights on the pathomechanisms of inflammatory bowel disease

Murdani Abdullah

Journal of Digestive Diseases, 2013

View PDFchevron_right

Increased Suppressor of Cytokine Signaling-3 Expression Predicts Mucosal Relapse in Ulcerative Colitis

Maikel Peppelenbosch

Inflammatory Bowel Diseases, 2013

View PDFchevron_right

New concepts in the pathophysiology of inflammatory bowel disease

Giorgos Bamias, S. De La Rue

Annals of internal medicine, 2005

View PDFchevron_right

Mucosal Gene Transcript Signatures in Treatment Naïve Inflammatory Bowel Disease: A Comparative Analysis of Disease to Symptomatic and Healthy Controls in the European IBD-Character Cohort

Morten Vatn

Clinical and Experimental Gastroenterology

View PDFchevron_right

Mucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitis

Jon Florholmen

Scandinavian Journal of Gastroenterology, 2012

View PDFchevron_right

Inflammatory Mediators Contributing to Intestinal Epithelial Cell Apoptosis and Barrier Disruption in IBD

Nancy Louis

Journal of Clinical & Cellular Immunology, 2012

View PDFchevron_right

Cellular and molecular mechanisms in the two major forms of inflammatory bowel disease

András Falus

2011

View PDFchevron_right

Recent therapeutic advances in inflammatory bowel disease

Jakob Seidelin

IDrugs : the investigational drugs journal, 2002

View PDFchevron_right

Review Article Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments

Bruno de Mattos

Mediators of Inflammation

View PDFchevron_right

Inflammatory Bowel Disease: A Genomic Picture Predicts a Changing Response From the Laboratory-Part I

Eric Staros

Laboratory Medicine, 2004

View PDFchevron_right

Interplay between Cellular and Molecular Mechanisms Underlying Inflammatory Bowel Diseases Development—A Focus on Ulcerative Colitis

Sorina Dinescu

Cells, 2020

View PDFchevron_right

Challenges in IBD Research: Preclinical Human IBD Mechanisms

Andres Hurtado-Lorenzo

Inflammatory Bowel Diseases, 2019

View PDFchevron_right

Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets

Felipe Varum

Translational Research, 2016

View PDFchevron_right

A gene expression map of colon tissue in ulcerative colitis: new methods rewrite old stories

Vasileios Papadopoulos

Biotarget

View PDFchevron_right

Dynamics of the Mucosa-Associated Flora in Ulcerative Colitis Patients during Remission and Clinical Relapse

Ateequr Rehman

Journal of Clinical Microbiology, 2008

View PDFchevron_right

Transcriptional Signatures That Define Ulcerative Colitis in Remission

Ruth Paulssen

Inflammatory Bowel Diseases

View PDFchevron_right

REDD1/Autophagy Pathway Is Associated with Neutrophil-Driven IL-1β Inflammatory Response in Active Ulcerative Colitis

Dimitrios Stakos

Journal of immunology (Baltimore, Md. : 1950), 2018

View PDFchevron_right

Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease

Gigi Veereman-wauters

Journal of Crohn's and Colitis, 2011

View PDFchevron_right

The severity of inflammation at onset of ulcerative colitis is not associated with IBS-like symptoms during clinical remission

Lena Ohman

Journal of Crohn's & colitis, 2015

View PDFchevron_right

Histological Hallmarks of Mucosal Healing in Inflammatory Bowel Diseases in the Era of Monoclonal Antibodies Therapy: New Insights and Perspectives

Valeria Andriola

Diagnostics

View PDFchevron_right

Editorial: Challenges in Inflammatory Bowel Disease: Current, Future and Unmet Needs

Raffaele Pellegrino

Frontiers in Medicine, 2022

View PDFchevron_right

Inflammatory bowel disease—From mechanisms to treatment strategies

Silvia Melgar

Autoimmunity, 2010

View PDFchevron_right

Ulcerative colitis: understanding its cellular pathology could provide insights into novel therapies

Amandip Kaur

Journal of Inflammation, 2020

View PDFchevron_right

Looking beyond gut inflammation in inflammatory bowel disease

ANCA CARDONEANU

2018

View PDFchevron_right

Prospects for Research in Inflammatory Bowel Disease

Warren Strober

JAMA, 2001

View PDFchevron_right

Downregulated Mucosal Autophagy, Alpha Kinase-1 and IL-17 Signaling Pathways in Active and Quiescent Ulcerative Colitis (original) (raw)

Related papers